Hi all, first post to HotCopper, have shared some info which might provide further context to discussion on potential pricing. Asahi Kasei Pharma(Japan Pharma) currently offer self-injectable Kevzara for treatment of Rheumatoid Arthritis at $600 per 150mg and $800 per 200mg, covered by Japan's public health insurance. Check out https://www.asahi-kasei.co.jp/asahi/en/news/2018/e181211.html. Same treatment also approved for inclusion in Australian PBS scheme in November last year but price info deleted - http://www.pbs.gov.au/industry/listing/elements/pbac-meetings/psd/2018-11/files/sarilumab-psd-november-2018.pdf
Interestingly, Asahi Kasei Pharma has a link to PPS for treatment of OA. In 2004, Bene PharmaChem and ReqMed commenced a collaboration for development of pentosan for treatment of OA. Following completion of two Phase 1 studies in Japan, the companies licensed Asahi Kasei to progress a Phase 2a study in Japan in 2010. Check out https://www.asahi-kasei.co.jp/asahi/en/news/2010/e100526.html. Cannot find any info regarding outcome of this study (others may?).
ReqMed is a current partner with Paradigm and Mount Sinai in current investigation of PPS to treat MPS. ReqMed developing the drug in Japan and other select Asian countries. Paradigm have rights to EU, US and some other countries not referenced. Refer https://www.mountsinai.org/about/newsroom/2019/mount-sinai-partners-with-paradigm-biopharmaceuticals-ltd-and-reqmed-company-ltd-to-repurpose-drug-to-battle-rare-mps-diseases
Trust above is of some use to holders.
- Forums
- ASX - By Stock
- PAR
- The Future
The Future, page-82
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 33599 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 65498 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20000 | 0.230 |
4 | 130009 | 0.225 |
12 | 183076 | 0.220 |
6 | 98958 | 0.215 |
9 | 260864 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 65498 | 1 |
0.245 | 48923 | 2 |
0.250 | 3443 | 1 |
0.260 | 58362 | 1 |
0.270 | 5000 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online